Kathleen Ford
Net Worth
Last updated:
What is Kathleen Ford net worth?
The estimated net worth of Ms. Kathleen Ford is at least $4,386,828 as of 18 Nov 2024. She owns shares worth $169,939 as insider, has earned $799,889 from insider trading and has received compensation worth at least $3,417,000 in Kura Oncology, Inc..
What is the salary of Kathleen Ford?
Ms. Kathleen Ford salary is $683,400 per year as Chief Operating Officer in Kura Oncology, Inc..
How old is Kathleen Ford?
Ms. Kathleen Ford is 78 years old, born in 1947.
What stocks does Kathleen Ford currently own?
As insider, Ms. Kathleen Ford owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Kura Oncology, Inc. (KURA) | Chief Operating Officer | 23,184 | $7.33 | $169,939 |
What does Kura Oncology, Inc. do?
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; and tipifarnib, an orally bioavailable inhibitor of farnesyl transferase that is in Phase II clinical trials for the treatment of solid tumors and hematologic indications. The company has a clinical collaboration with Novartis to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression or PIK3CA mutation and/or amplification. Kura Oncology, Inc. was founded in 2014 and is headquartered in San Diego, California.
Kathleen Ford insider trading
Kura Oncology, Inc.
Ms. Kathleen Ford has made 8 insider trades between 2020-2024, according to the Form 4 filled with the SEC. Most recently she sold 526 units of KURA stock worth $8,434 on 18 Nov 2024.
The largest trade she's ever made was exercising 9,375 units of KURA stock on 15 Dec 2020. As of 18 Nov 2024 she still owns at least 23,184 units of KURA stock.
Kura Oncology key executives
Kura Oncology, Inc. executives and other stock owners filed with the SEC:
- Dr. Marc Grasso (52) Chief Financial Officer & Chief Bus. Officer
- Dr. Stephen Dale M.D. (53) Chief Medical Officer
- Dr. Troy Edward Wilson (56) Chairman, Chief Executive Officer & Pres
- Ms. Kathleen Ford (78) Chief Operating Officer
- Ms. Kirsten Flowers (50) Chief Commercial Officer